Table 4 Schedule of surveillance, interviews and consent interactions in the main JiVitA-1 trial
Survey/Questionnaire | Scheduled at | Contents | Conducted by * | Consent/Reconsent |
|---|---|---|---|---|
Women's Enrollment Survey | Beginning of trial | Baseline census of all women of reproductive age, enrollment into surveillance | FD | Y |
Newly Married Woman Survey | Ongoing, 5- weekly | Allows enrollment of eligible, newly married women | FD | Y |
Pregnancy Surveillance Survey | Ongoing, 5- weekly | Urinary hCG-based identification of new pregnancies | FD | Y, for urine test |
Women's Consent Interview | Pregnancy identification | Informing women about the trial, obtaining consent for interviews and supplementation | TL | Y |
Pregnancy Dosing Visits | Weekly | Weekly supplementation of enrolled pregnant women | FD | N |
Pregnancy Enrollment Questionnaire | First week after consent | Baseline characteristics, pregnancy history, 7 d diet, 7 d/30 d morbidity, exposures | FI | N |
Socioeconomic Status Questionnaire | First week after consent | Education, employment of self and husband, household assets | FI | N |
Family History Questionnaire | First week after consent | Parental vital status, cause of death, chronic morbidity | FI | N |
Late Pregnancy Questionnaire | At 28 weeks gestation | 7 d diet, 7 d/30 d morbidity, exposures | FI | N |
Three-Month Postpartum Questionnaire | At 12 weeks postpartum | Complications of labor and delivery, 7 d diet, 7 d/30 d morbidity, exposures | FI | N |
Six-Month Postpartum Questionnaire | At 24 weeks postpartum | 7 d diet, 7 d/30 d morbidity, exposures | FI | N |
Miscarriage/Stillbirth Questionnaire | 4 weeks after event | Complications of labor and delivery, care-seeking | FI | Y |
Verbal Autopsy - Infant | 4 weeks after event | Enhanced from WHO standard instrument | FI | Y |
Verbal Autopsy - Mother | 4 weeks after event | Enhanced from WHO standard instrument | RP | Y |